Athens Research/Cambio - Excellence in Molecular Biology/0.25g/10-1091-02

价格
面议
货号:10-1091-02
浏览量:127
品牌:Athens Research
服务
全国联保
正品保证
正规发票
签订合同
商品描述
Oligo Synthesis

Oligo Synthesis : CEPs

Prices quoted are for single packs only. For multiples of the same product please request a quote. Some of Glen"sproductsarehazardousandmay be subject to additional shipping charges. Full product information is available onGlen Research"s website.

  • Catalogue
  • Description
  • Protocols
  • Notes
  • Applications & Benefits

5-I-dU-CE Phosphoramidite

5-I-dU-CE Phosphoramidite

Glen Research

Catalogue No.DescriptionPack SizePriceQty
  • Change to:
  • €
10-1091-025-I-dU-CE Phosphoramidite0.25g£128.00£121.60Offer until : 31-Mar-2021Offer Code : GLEN55% off all Glen productsView OfferQuantityAdd to Order
10-1091-905-I-dU-CE Phosphoramidite100µmoles£48.00£45.60Offer until : 31-Mar-2021Offer Code : GLEN55% off all Glen productsView OfferQuantityAdd to Order

5-I-dU-CE Phosphoramidite

5-I-dU-CE Phosphoramidite

Glen Research

5-I-dU-CE Phosphoramidite

Structure

Catalog Number: 10-1091-xx

Description: 5-I-dU-CE Phosphoramidite

5"-Dimethoxytrityl-5-iodo-2"-deoxyUridine,3"-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite
Formula: C39H46IN4O8PM.W.: 856.69F.W.: 416.07

Diluent: Anhydrous Acetonitrile
Coupling: No changes needed from standard method recommended by synthesizer manufacturer.
Deprotection: Mild deprotection: Ammonium Hyrdoxide for 24 hours at room temperature
Storage: Refrigerated storage, maximum of 2-8°C, dry
Stability in Solution: 24 hours

HALOGENATED NUCLEOSIDES

Brominated and iodinated nucleosides are used in crystallographystudies of oligonucleotide structure. They are also photolabile and are used forcross-linking studies to probe the structure of protein-DNA complexes.Antibodies exist to Br-dU and oligonucleotides containing Br-dU can be used asprobes.

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

5-I-dU-CE Phosphoramidite

5-I-dU-CE Phosphoramidite

Glen Research

MSDS

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

5-I-dU-CE Phosphoramidite

5-I-dU-CE Phosphoramidite

Glen Research

Oligonucleotides containinga bromo or iodo group are prepared conventionally with the exception that deprotection is carried out in ammonium hydroxide at room temperature for 24 hours. Under these conditions, degradation of the halogen group was less than 2%.

Frequently Asked Technical Question

QUESTION: What methods are available for crosslinking DNA with DNA, RNA, proteins?

RESPONSE:The most widely used method seems to be using Br-dU and, more recently, I-dU (1).The substitution of photoreactive Br and I for the 5-Me group of thymidine is attractive since their radii are similar to that of the methyl group.These modifications do not significantly affect the binding of oligonucleotides with proteins.Br-dU is irradiated at 308nm and crosslinking is typically not greater than 40%.Crosslinking of I-dU at 308nm is higher but is optimal at 325nm.Laser excitation is preferred.

After the synthesis of oligonucleotides containing Br-dU or I-dU, care must be taken to avoid loss of the halogens.Even though both modifications are quite stable to ammonium hydroxide, it is sensible to play safe and carry out the deprotection at room temperature for 24 hours.Even better, use the UltraMild monomers and deprotect with potassium carbonate in methanol at room temeperature.The oligonucleotide products should be protected from light - plastic tubes and amber vials are safe.Gel electrophoresis should be carried out protected from light.

REFERENCE(S):(1)M.C. Willis, B.J. Hicke, O.C. Uhlenbeck, T.R. Cech and T.H. Koch, Science, 1993, 262, 1255.


QUESTION: What are the extinction coefficients for propynyl-dC and dU?Also Halogenated dC and dU derivatives?Others?

RESPONSE:See: Table of Extinction Coefficients

REFERENCE(S):B. Froehler, GileadM. PowellR. Somers

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

5-I-dU-CE Phosphoramidite

5-I-dU-CE Phosphoramidite

Glen Research

EXTINCTION DATA

ItemNucleosideλMax-1Emax-1λMax-2Emax-2E260
(nm)(ml/µmole)nm(ml/µmole)(ml/µmole)
10-10915-I-dU2877.73.7

DILUTION/COUPLING DATA

The table below shows pack size data and, for solutions, dilutions and approximate couplings based on normal priming procedures.

ABI 392/394
Cat.No.PackSizeGrams/Pack0.1M Dil.(mL)LV40LV20040nm0.2µm1µm10µm
Approximate Number of Additions
10-1091-020.25grams.25grams2.928450.431.522.9116.84.2
10-1091-90100µmoles.086grams120127.55.4541
Expedite
Cat.No.PackSizeGrams/PackDilution(mL)Molarity50nm0.2µm1µm15µm
Approximate Number of Additions
10-1091-020.25grams.25grams4.36.0780.850.536.735.05
10-1091-90100µmoles.086grams1.5.0723.614.7510.731.48
Beckman
Cat.No.PackSizeGrams/PackDilution(mL)Molarity30nm200nm1000nm
Approximate Number of Additions
10-1091-020.25grams.25grams4.36.0782.451.537.45
10-1091-90100µmoles.086grams1.5.0725.215.7511.45

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

Myeloperoxidase Enzyme Immunoassay Kit 髓过氧化物酶 免疫分析试剂盒 Human MPO EIA KIT FEATURES: USE - Measure human MPO in a variety of matrices SAMPLE -Serum, Platelet-Poor Heparin Plasma, Saliva, Urine or Tissue Culture Media SAMPLES / KIT - 40 in duplicate SENSITIVITY - 0.068 ng/mL STABILITY - liquid reagents stable at 4°C QUICK RESULTS - 2.5 HOURS Myeloperoxidase (MPO) is a tetrameric heme-containing protein abundantly produced in neutrophil granulocytes where it plays an important anti-microbial role. During degranulation MPO is released into the extracellular space. There, as part of the neutrophils “respiratory burst”, it produces hypochlorous acid from hydrogen peroxide and Cl–. MPO also uses hydrogen peroxide to oxidize tyrosine to the tyrosyl radical. Both hypochlorous acid and tyrosyl are cytotoxic and when present can kill bacteria and other pathogens. Hereditary deficiency of myeloperoxidase predisposes individuals to immune deficiency. Studies have shown an association between elevated MPO levels and coronary artery disease, and in 2003 it was suggested that MPO may serve as a sensitive predictor of myocardial infarction in patients complaining of chest pain. Since that time the clinical utility of MPO testing in cardiac patients has been solidly established in the literature with well over 100 papers published. In 2010 this clinical application was further refined by additional studies which determined that measuring both MPO and C-reactive protein (CRP) provided more accurate prediction of mortality risk than measuring just CRP alone.